Our high-purity small molecule intermediates accelerate drug discovery and development. Manufactured under strict cGMP standards, they ensure consistent quality, reduce synthesis steps, and streamline scale-up—helping you bring critical therapies to patients faster. Partner with us to de-risk your pipeline.
They shorten your development timeline by enabling faster synthesis, helping you bring critical therapies to market sooner.
Manufactured under strict cGMP standards, they ensure consistent quality and purity, de-risking your entire production scale-up.
They simplify your supply chain with end-to-end support, from development to commercial supply, making your process more efficient.
High purity is critical for predictable reactions and final drug safety. We ensure rigorous quality control and testing for every batch.
The synthetic pathway impacts efficiency, cost, and scalability. We collaborate to design and optimize the most effective route for your project.
A smooth transition from lab to plant is essential. We develop robust, reproducible processes to ensure a reliable supply at any volume.
Full cGMP compliance and comprehensive documentation are mandatory. We provide complete support for all regulatory and filing requirements.
A stable, long-term supply chain mitigates project risk. We guarantee consistent, on-schedule delivery through strategic planning and partnerships.
B608, #25 Shenbin Rd, Minhang District, Shanghai, China
English
